Harshman, L. C., Wang, X. V., Hamid, A. A., Santone, G., Drake, C. G., Carducci, M. A., . . . Sweeney, C. J. (2020). Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805). Prostate.
Citação norma ChicagoHarshman, Lauren C., X. Victoria Wang, Anis A. Hamid, Gabriella Santone, Charles G. Drake, Michael A. Carducci, Robert S. DiPaola, Raina N. Fichorova, and Christopher J. Sweeney. "Impact of Baseline Serum IL-8 On Metastatic Hormone-sensitive Prostate Cancer Outcomes in the Phase 3 CHAARTED Trial (E3805)." Prostate 2020.
Citação norma MLAHarshman, Lauren C., et al. "Impact of Baseline Serum IL-8 On Metastatic Hormone-sensitive Prostate Cancer Outcomes in the Phase 3 CHAARTED Trial (E3805)." Prostate 2020.